European Commission President Ursula von der Leyen is once again under intense scrutiny-this time facing the prospect of a no ...

Supporters of a motion of censure against Commission President Ursula von der Leyen hope it will put enough political ...

The political mainstream will prevent the Commission from falling, but even a doomed no-confidence vote would refocus ...

European Commission President Ursula von der Leyen is under fire as far-right Members of the European Parliament (MEPs) push ...

Far-right motion relating to pandemic scandal threatens to derail European Commission president’s second-term agenda ...

Pfizer’s Q1 earnings call delivered a rollercoaster of cautious optimism. CEO Albert Bourla credited solid execution in ...

Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...

Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order ...

The Health Secretary's attended the Bilderberg Meeting in Sweden, sipping champagne in the company of billionaires, bankers ...

PwC analysts have warned the speedy evolution of the Chinese biotech sector is creating “heightened risks related to IP ...